• Hepatitis E IgM serology update


    NVRL has just been notified of manufacturer supply issues with the BioMerieux Vidas HEV IgM assay. Due to factors beyond our control the implementation of the Liaison HEV IgM assay and supplementary second line Vidas HEV IgM will be delayed. We will issue further updates as available.


    Posted By Brian O'Grady read more
  • Change in NVRL Hepatitis E screening: UPDATE to be introduced 28th November 2022


    NVRL is replacing the Fortress HEV IgM assay in favour of Diasorin Liaison XL HEV IgM assay and also introducing a supplementary second line Vidas HEV IgM assay to confirm Diasorin reactive samples.

    The Diasorin and Vidas HEV IgM assays have comparable sensitivity. However, by using two assays in combination, we can generate improved specificity in comparison with Fortress HEV IgM alone, whilst also allowing for increased automation.

    NVRL IT department will provide specific information including relevant test request codes.

    Posted By Helen.Dawkins read more
  • NVRL LIMS upgrade – some test results may be affected


    Laboratory Information Management System (LIMS)

    We are currently in the process of transitioning to a new version of our LIMS. This may lead to a delay in reporting results for the following:

    Chlamydia trachomatis, Neisseria gonorrhoeaeMycoplasma genitalium and Trichomonas vaginalis.

    We thank you for your patience at this time and are working hard to limit any potential impact during this period.


    Please contact NVRL on 01-7164401 if you have any queries.


    Posted By Helen.Dawkins read more
  • Human Monkeypox Virus Testing at NVRL


    As of today, October 24th 2022, UCD NVRL is reducing Monkeypox Virus (MPXV) testing to three days per week (Monday, Wednesday and Friday).

    This is due to both the reduction in sample numbers received for testing and the overall positivity rate.

     Samples received by 11AM will be reported the same day.  Any sample received after this time will be stored on site for the next run.

    Posted By Helen.Dawkins read more
  • IT Network issues

    Due to an unforeseen IT network issue, there may be a delay in reporting some tests.
    The NVRL sincerely apologises for any inconvenience caused as a result of this service disruption.
    Posted By Brian O'Grady read more
  • NVRL is pleased to Advise Customers of our new EIRCODE


    NVRL is very pleased to inform customers that an Eircode has been assigned.

    Please see below. This Eircode should aid deliveries in locating our premises.

    Please address any queries to the Customer Care Officer at 01-7161257

    EirCode finder

    Posted By Helen.Dawkins read more
  • Handling of samples from suspected Monkeypox virus (MPXV) cases


    The current outbreak of Human Monkeypox infections (HMI) has resulted in samples being sent to UCD NVRL for Orthopox and MPXV West African Clade specific PCR. 

    It is vital that samples for MPXV are transported to UCD NVRL as a Category A pathogens. Please see here the link to the Health Protection Surveillance Centre (HPSC) regarding transport of these samples.

    Posted By Helen.Dawkins read more
  • Customer Notifications regarding Extended Expiry Dating of some Aptima Lots


    Please see below links to Customer Technical Bulletins that were received from Hologic in response to recent shortages of Aptima Collection Devices (ACDs). This CN has been updated 21st June 2022.

    Extended Expiry Dating studies were completed at Hologic and the links below contain data relating to lot numbers for Urine and Multitest Collection Kits and updated expiry dates.

    Posted By Helen.Dawkins read more
  • Changes to NVRL testing, regarding Measles IgM and Rubella IgM


    Changes to NVRL testing, regarding Measles IgM and Rubella IgM


    Following a review of testing at NVRL, it was noted that Measles IgM investigations were being requested as part of a general viral screen.  Measles IgM testing should be performed when there is a high index of suspicion that the patient has an acute measles infection.  In addition, an oral fluid sample should be collected for measles RNA, to facilitate genotyping to identify transmission pathways

    Posted By Helen.Dawkins read more
  • Re-introduction of HIV Resistance Testing at NVRL


    NVRL is delighted to inform our users that the suspension of in-house HIV Drug Resistance testing (test code ARIA) has ended.

    NVRL is now completing testing in-house and specimens will no longer be referred to the UK.

    This CN replaces earlier Notifications, published in 2021 (CN-21-13 and CN-21-25)

    NVRL sincerely apologises for any inconvenience that was caused during the suspension. Please contact the Clinical Team with any queries on 01-7164401

    (Reference: CN-22-7)

    Posted By Helen.Dawkins read more